Company Overview
American Healthcare Capital is pleased to exclusively introduce an innovative MedTech inventor and developer that has created a technology breakthrough, patent-protected Airway Device. This device is designed to reduce or eliminate hypoxia during difficult intubations, marking a significant advancement in emergency medical technology. The device has demonstrated remarkable results in preclinical trials and promises to be a game-changer in emergency and critical care settings. Research has shown that in large animals whose breathing had stopped, the Airway Device maintained oxygen levels above 97% for over 16 minutes.
The device is patent-protected with 2 issued patents and 4 patents pending and is FDA-Registered as a Class 1 device. It is designed to get oxygen into the lungs in the critical phases of intubation even if the patient is not breathing. This medical device attaches to Endotracheal Tubes and is predicted to prevent or reduce life-threatening hypoxia. It is designed to provide an extended safe apnea period during difficult endotracheal intubation attempts.
Financial Forecast
The product line will be ending its pre-revenue stage by the end of 2024. Contract manufacturing has been engaged and sales distribution is in progress for its FDA-cleared innovative device. The device is expected to have a 60% to 70% gross profit margin, which will increase with scale. The preferred channel of distribution for this product will be to combine with the endotracheal tube market segment. This will be utilized for emergency treatment in hospitals, ambulatory surgery centers, specialty clinics, and research centers. The Company is forecasting $50 million in revenues in 2027 with an EBITDA of $17.6 million (35%).
The global endotracheal tube market size was valued at USD $2.2 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 6.20% from 2023 to 2030. The demand for endotracheal tubes is increasing due to technological advancements such as anti-fouling coating products, a significant increase in surgeries, strategic initiatives by key companies, and increasing incidences of chronic diseases. There has been a rise in the prevalence of chronic diseases like urological disorders, cancer, stroke, cardiovascular disorders, and neurovascular diseases, among other chronic problems.
The Company is an inventor and developer of multiple medical device products and is looking for a strategic or financial partner to add value through its connections, financial strength, and resources to grow this MedTech Airway Device Product to the next level. Therefore, the founders will consider a buyout of this Product Line in support of the future growth potential for this innovative technology product.
Asking Price
The Price is to Be Determined, with or without an Earnout Going Forward.
